The Value of Bio-electrical Impedance Analysis in Irritable Bowel Syndrome (BIA-IBS)
Irritable Bowel Syndrome
About this trial
This is an interventional other trial for Irritable Bowel Syndrome
Eligibility Criteria
Inclusion Criteria: Patients aged 18 - 75 years; Fulfilling the ROME IV criteria for IBS (only for patients); Exclusion Criteria: Clinical suspicion of an organic disorder different from IBS (patients can be included when this disorder had been excluded); Known inflammatory bowel disorder; Known major intestinal motility disorder; Alcohol (defined as more than 14 U per week) or other substance abuse; Active psychiatric disorder; Known systemic or auto-immune disorder with implication for the GI system; Prior abdominal surgery (with the exception of cholecystectomy or ap-pendectomy); Any prior diagnosis of cancer other than basocellular carcinoma; Current chemotherapy; History of gastro-enteritis in the past 12 weeks; Dietary supplements unless taken at a stable dose for more than 12 weeks; Treatment with neuromodulators (one neuromodulator taken at a sta-ble dose for more than 12 weeks is allowed); Pregnancy.
Sites / Locations
- UZ BrusselRecruiting
Arms of the Study
Arm 1
Arm 2
Other
Other
IBS patients
Healthy volunteers